Market Update on Notable Stocks
Today, several companies have emerged as significant players in intraday trading, particularly in the semiconductor sector. With the VanEck Semiconductor ETF (SMH) enjoying its best quarter to date, semiconductor stocks have seen impressive gains. The ETF was on track for a remarkable 70% increase in the second quarter, closing the day up over 3%. Individual companies such as Astera Labs saw a 7% rise, KLA Corp increased by 8%, and Applied Materials gained 5%.
Turning to Watts Water Technologies, the manufacturer of water valves and hot water solutions, shares surged more than 7% following an upgrade to Overweight by Barclays. The firm indicated that Watts is “best positioned” among those in the waste and water technology sectors, particularly to capitalize on the data center investment cycle as its product offerings expand to include plumbing, drainage, and cooling solutions for data centers.
In the biotech sphere, French company Avivax’s U.S.-traded shares skyrocketed by 40% after it released new data regarding its treatment for ulcerative colitis. The data suggested that occurrences of malignancy were within expected ranges, and notably, over 37% of patients who hadn’t responded to previous treatments achieved clinical remission after roughly 10 months at a 50mg dose.
SolarEdge Technologies, known for its inverter systems, increased by 7% after reports emerged that the Trump administration is contemplating a ban on foreign-made inverters. Enphase Energy also saw a minor bump, rising 2%.
Air Products and Chemicals experienced an 8% rise in share value after announcing it would halt a clean energy complex project in Louisiana. The decision stemmed from the anticipated financial outcomes being below expectations. Consequently, Air Products also indicated it would incur a pre-tax charge near $2.9 billion in its upcoming fiscal third quarter.
Conversely, Zimmer Biomet’s shares dipped by 7% following Pacira BioSciences’ announcement about selling its Iovera pain treatment system to Zimmer for $140 million. On a different note, AeroVironment, the drone manufacturer, jumped about 17% after reporting stronger profits and revenue. The company earned $1.84 per share with total revenue of $642 million, outpacing analyst estimates.
Digital Realty Trust, a real estate investment trust, saw a decline of nearly 5% after it agreed to acquire a stake in three fully leased data centers for $7.8 billion from Blackstone. Meanwhile, Merck and AbbVie each lost less than 1% after a U.S. House committee initiated an investigation into their involvement in clinical trials conducted in China related to military support.
Bouncing over to cryptocurrency-related stocks, proxy stocks fell around 7%, reversing some of Monday’s gains. In pre-market trading, Strategy surged 22.6%, breaking an eight-day losing streak, marking its largest single-day gain since February 6. Bitcoin’s value also dropped, falling more than 3% to approximately $58,430.
Lastly, shares of Seras Life Sciences fluctuated, finishing down 4%. The company had seen a nearly 25% rise on Monday after announcing adjustments to executive employment contracts involving retirement benefits. This might be a normal update, or it could hint at a potential takeover on the horizon.
